ss-31 elamipretide or mots-c or dihexa neuroprotection anesthesia or surgery Reboot Your Energy: & Peptides Explained SS-31 (Elamipretide): Revolutionizing Mitochondrial Dysfunction
Description
Inconsistent dosing: GHK-Cu works through cumulative collagen remodeling
George Collins Contributor George Collins is a neuropharmacologist specializing in neuroscience and a contributor at WholisticResearch
Wang et al
The Phase 2 data proves it: fast escalation to 8 mg doubled GI adverse event rates compared to gradual titration
Monitoring of infliximab trough levels (target: 37 mg/mL) will determine whether dosing can be increased to 5mg/kg every 4 weeks or 10mg/kg every 8 weeks[75]
(Epub 2015 Jun 4 PMID: 26052041)
